![Ronald Evans](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ronald Evans
Director/Board Member at
The Salk Institute for Biological Studies
Profile
Ronald M.
Evans is the founder of Ligand Pharmaceuticals, Inc. (1987), Syndax Pharmaceuticals, Inc. (2005), Synchronicity Pharma, Inc. (2008), Mitobridge, Inc. (2013), and Metacrine, Inc. (2014).
He is also the founder of Xenopharm, Inc., X-Ceptor Therapeutics, Inc., XTuit Pharmaceuticals, Inc. Dr. Evans's current jobs include Director & Professor at The Salk Institute for Biological Studies, Director at American Association for Cancer Research, Member at National Academy of Sciences, Member at American Academy of Arts & Sciences, and Member at National Academy of Medicine (United States).
Dr. Evans received his doctorate degree from the University of California, Los Angeles in 1974 and his undergraduate degree from the same university in 1970.
Ronald Evans active positions
| Companies | Position | Start |
|---|---|---|
The Salk Institute for Biological Studies
 The Salk Institute for Biological Studies Other Consumer ServicesConsumer Services Functions as a College/University | Director/Board Member | - |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Corporate Officer/Principal | 2010-01-24 |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Corporate Officer/Principal | 2010-01-24 |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Corporate Officer/Principal | 2010-01-24 |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Director/Board Member | - |
Former positions of Ronald Evans
| Companies | Position | End |
|---|---|---|
| METACRINE, INC. | Founder | 2023-03-22 |
Mitobridge, Inc.
 Mitobridge, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Founder | - |
XTuit Pharmaceuticals, Inc.
 XTuit Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Founder | - |
Synchronicity Pharma, Inc.
 Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Discovers, develops and commercializes novel therapeutics | Founder | - |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
Training of Ronald Evans
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
88
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
The Salk Institute for Biological Studies
The Salk Institute for Biological Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syndax Pharmaceuticals, Inc.
 Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Xenopharm, Inc.
 Xenopharm, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drug sensing molecules | Commercial Services |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
X-Ceptor Therapeutics, Inc.
 X-Ceptor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development of small molecule therapeutics | Commercial Services |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Commercial Services |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Commercial Services |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Commercial Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
Synchronicity Pharma, Inc.
Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Discovers, develops and commercializes novel therapeutics | Health Technology |
XTuit Pharmaceuticals, Inc.
XTuit Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Mitobridge, Inc.
Mitobridge, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Metacrine, Inc.
 Metacrine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in discovery and development of therapies for patients with liver and gastrointestinal diseases | Health Technology |
- Stock Market
- Insiders
- Ronald Evans
